3 ASX All Ords stocks smashing the benchmark this week

Investors sent these three ASX All Ords stocks soaring this week. But why?

| More on:
Boys making faces and flexing.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The All Ordinaries Index (ASX: XAO) is up 1.4% over the Australia Day holiday-shortened trading week, with three ASX All Ords stocks doing more than their share of the heavy lifting.

One provides data solutions and services for machine learning and artificial intelligence (AI).

The second is an Australian gaming technology company.

And the third outperforming ASX All Ords stock on my list is a clinical-stage biotechnology company.

Which high-flying stocks am I talking about?

Read on!

Three ASX All Ords stocks roaring higher

The first ASX All Ords stock to deliver shareholders outsized gains this week is Mesoblast Ltd (ASX: MSB).

Shares in the company, which specialises in allogeneic cellular medicines to treat inflammatory diseases, closed last Friday trading for $2.87. At the time of writing today, shares are changing hands for $3.12 apiece, up 10.6%.

That brings the Mesoblast share price gains over the past year to… wait for it… 1,055%!

Mesoblast share enjoyed an added push higher today following the release of the company's fourth-quarter results and trading update.

Investors have been bidding up the share price as Mesoblast continues to make significant progress with a range of its promising drug candidates. That included receiving US Food and Drug Administration (FDA) approval in the December quarter for its Ryoncil (remestemcel-L) product for the treatment of steroid-refractory acute graft versus host disease.

Moving on to our second high-performing ASX All Ords stock of the week, we have Aristocrat Leisure Ltd (ASX: ALL).

Shares in the gaming technology company closed last Friday at $68.95. At the time of writing, those same shares are trading for $75.04, up 10.6%.

This sees the Aristocrat Leisure share price up 69% in a year. Aristocrat shares also trade on a partly franked trailing dividend yield of 1.1%.

There has been no price-sensitive news from Aristocrat since the company released its full-year results in November. But the stock may have gotten an added boost this week after Goldman Sachs upgraded it to a buy rating with a price target of $78.00 a share.

Which brings us to our third outperforming ASX All Ords stock for the week, Appen Ltd (ASX: APX).

Shares in the language data-focused tech company closed last Friday trading for $2.45. At the time of writing today, they are swapping hands for $2.75 each, up 10.9%.

With the past week's gains factored in, the Appen share price is up a blistering 733% in a year.

Much of those gains were delivered today, following yesterday's release of Appen's December quarter update.

The company reported fourth-quarter revenue of $66.7 million, up 23.3% from the prior quarter. The revenue boost was spurred by growth in Appen's generative AI projects.

Should you invest $1,000 in Aristocrat Leisure Limited right now?

Before you buy Aristocrat Leisure Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Aristocrat Leisure Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Appen and Goldman Sachs Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Nine, Qualitas, Woodside, and Zip shares are storming higher today

These shares are having a strong session on Tuesday.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a rocky but positive start to the week's trading this Monday.

Read more »

Ecstatic man giving a fist pump in an office hallway.
Share Gainers

Why APA, Aussie Broadband, Neuren, and NIB shares are charging higher today

These shares are starting the week on a positive note. But why?

Read more »

A runner high-fives as he crosses the finish line in pole position
Share Gainers

Here are the top 10 ASX 200 shares today

It was a woeful end to a woeful week this Friday for ASX investors.

Read more »

Siblings jumping on a trampoline.
Share Gainers

3 ASX 200 stocks rocketing higher in this week's falling market

These three ASX 200 outperformers have surged 17% to 28% this week!

Read more »

A man wearing a white coat holds his hands up and mouth open with joy.
Healthcare Shares

Guess which ASX healthcare stock is rocketing 25% on big UK news

Investors are sending this ASX healthcare stock rocketing on Friday. But why?

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Share Gainers

Why Domain, Mayne Pharma, QBE, and Telix shares are jumping today

These shares are ending the week with a bang. Here's why they are jumping.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an awful Thursday for ASX investors.

Read more »